Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ADMS

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADMS
DateTimeSourceHeadlineSymbolCompany
10/12/20217:02AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/12/20217:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
10/11/20216:30AMGlobeNewswire Inc.Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product PortfolioNASDAQ:ADMSAdamas Pharmaceuticals Inc
10/08/20214:15PMBusiness WireAdamas Announces New Employment Inducement GrantsNASDAQ:ADMSAdamas Pharmaceuticals Inc
10/01/20219:15AMBusiness WireAdamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health AwardsNASDAQ:ADMSAdamas Pharmaceuticals Inc
09/16/20219:15AMBusiness WireAdamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) CongressNASDAQ:ADMSAdamas Pharmaceuticals Inc
09/10/20215:00PMBusiness WireAdamas Announces New Employment Inducement GrantsNASDAQ:ADMSAdamas Pharmaceuticals Inc
08/30/20214:11PMBusiness WireAdamas to Present at Upcoming September Investor ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
08/13/20214:16PMBusiness WireAdamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
08/09/20214:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
08/09/20214:02PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
08/09/20214:01PMBusiness WireAdamas Reports Second Quarter 2021 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
08/02/20214:02PMBusiness WireAdamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021NASDAQ:ADMSAdamas Pharmaceuticals Inc
07/22/20219:15AMBusiness WireAdamas Announces Issuance of New Patents for GOCOVRI and ADS-4101NASDAQ:ADMSAdamas Pharmaceuticals Inc
07/09/20214:05PMBusiness WireAdamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
07/08/20214:02PMBusiness WireAdamas to Present at Upcoming William Blair Biotech Focus ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
06/23/20214:42PMBusiness WireAdamas to Present at Upcoming SVB Leerink CNS ForumNASDAQ:ADMSAdamas Pharmaceuticals Inc
06/11/20214:08PMBusiness WireAdamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
06/11/20214:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/10/20219:15AMBusiness WireNew Data Analysis Supports GOCOVRI as an Important Treatment for Motor Complications for People With Parkinson’s DiseaseNASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
06/04/20214:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
05/27/20214:11PMBusiness WireAdamas to Present at Upcoming June ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
05/10/20214:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADMS